Armenien - engelska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

morningside pharmaceuticals ltd - metformin (metformin hydrochloride) - tablets prolonged-release - 1000mg

Armenien - engelska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

morningside pharmaceuticals ltd - metformin (metformin hydrochloride) - tablets prolonged-release - 500mg

Armenien - engelska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

morningside pharmaceuticals ltd - metformin (metformin hydrochloride) - tablets prolonged-release - 1000mg

Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - liquid - see ingredients - each 5,0 ml liquid contains betamethasone 0,25 mg dexchlorpheniramine maleate 2,0 mg

Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - tablet - 250,0 mcg/2,0 mg - each tablet contains betamethasone 250,0 mcg and dexchlorpheniramine 2,0 mg

Kanada - engelska - Health Canada

bayer inc - larotrectinib (larotrectinib sulfate) - capsule - 25mg - larotrectinib (larotrectinib sulfate) 25mg - antineoplastic agents

Kanada - engelska - Health Canada

bayer inc - larotrectinib (larotrectinib sulfate) - capsule - 100mg - larotrectinib (larotrectinib sulfate) 100mg - antineoplastic agents

Malaysia - engelska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - fingolimod hydrochloride -

Israel - engelska - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - film coated tablets - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.02 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations - - oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who choose to use an oral contraceptive as their method of birth control.- treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. - in women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.

Malaysia - engelska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - fingolimod hydrochloride -